Question 1

Am I eligible for this trial based on my current medications and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes clinical trial (NCT00103935). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Exenatide LAR compare to my current diabetes treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes clinical trial (NCT00103935). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of Exenatide LAR?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes clinical trial (NCT00103935). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes clinical trial (NCT00103935). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected duration of treatment in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes clinical trial (NCT00103935). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my diabetes management be closely monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes clinical trial (NCT00103935). Contact the study team or your healthcare provider for specific answers.

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Feasibility of a Tailored Online Self-compassion Intervention

Achieving Routine Intervention and Screening for Emotional Health

Human Immunodeficiency Virus (HIV) Food Insecurities

Trial snapshot

Condition

Locations shown

For caregivers